153 related articles for article (PubMed ID: 17343830)
1. Inhibition of G1/S transition potentiates oxaliplatin-induced cell death in colon cancer cell lines.
Rakitina TV; Vasilevskaya IA; O'Dwyer PJ
Biochem Pharmacol; 2007 Jun; 73(11):1715-26. PubMed ID: 17343830
[TBL] [Abstract][Full Text] [Related]
2. Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines.
Atallah D; Marsaud V; Radanyi C; Kornprobst M; Rouzier R; Elias D; Renoir JM
Int J Hyperthermia; 2004 Jun; 20(4):405-19. PubMed ID: 15204521
[TBL] [Abstract][Full Text] [Related]
3. p53 dependent and independent sensitivity to oxaliplatin of colon cancer cells.
Toscano F; Parmentier B; Fajoui ZE; Estornes Y; Chayvialle JA; Saurin JC; Abello J
Biochem Pharmacol; 2007 Aug; 74(3):392-406. PubMed ID: 17559811
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
[TBL] [Abstract][Full Text] [Related]
5. G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells.
Yoshida J; Ishibashi T; Nishio M
Biochem Pharmacol; 2007 Apr; 73(7):943-53. PubMed ID: 17217918
[TBL] [Abstract][Full Text] [Related]
6. Opposing securin and p53 protein expression in the oxaliplatin-induced cytotoxicity of human colorectal cancer cells.
Chiu SJ; Hsu TS; Chao JI
Toxicol Lett; 2006 Dec; 167(2):122-30. PubMed ID: 17045763
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines.
Noordhuis P; Laan AC; van de Born K; Losekoot N; Kathmann I; Peters GJ
Biochem Pharmacol; 2008 Jul; 76(1):53-61. PubMed ID: 18508032
[TBL] [Abstract][Full Text] [Related]
8. Lethality, DNA alkylation, and cell cycle effects of adozelesin (U-73975) on rodent and human cells.
Bhuyan BK; Smith KS; Adams EG; Petzold GL; McGovren JP
Cancer Res; 1992 Oct; 52(20):5687-92. PubMed ID: 1394193
[TBL] [Abstract][Full Text] [Related]
9. Dose- and time-dependent effects of doxorubicin on cytotoxicity, cell cycle and apoptotic cell death in human colon cancer cells.
Lüpertz R; Wätjen W; Kahl R; Chovolou Y
Toxicology; 2010 May; 271(3):115-21. PubMed ID: 20346999
[TBL] [Abstract][Full Text] [Related]
10. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.
Petak I; Tillman DM; Houghton JA
Clin Cancer Res; 2000 Nov; 6(11):4432-41. PubMed ID: 11106264
[TBL] [Abstract][Full Text] [Related]
11. Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression.
Song JD; Kim KM; Kim KH; Kim CD; Kim JM; Yoo YH; Park YC
Int J Oncol; 2008 Dec; 33(6):1299-306. PubMed ID: 19020764
[TBL] [Abstract][Full Text] [Related]
12. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
Sakoff JA; Howitt IJ; Ackland SP; McCluskey A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
Adamsen BL; Kravik KL; Clausen OP; De Angelis PM
Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676
[TBL] [Abstract][Full Text] [Related]
14. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer.
Hogan FS; Krishnegowda NK; Mikhailova M; Kahlenberg MS
J Surg Res; 2007 Nov; 143(1):58-65. PubMed ID: 17950073
[TBL] [Abstract][Full Text] [Related]
15. Deoxycholic acid and selenium metabolite methylselenol exert common and distinct effects on cell cycle, apoptosis, and MAP kinase pathway in HCT116 human colon cancer cells.
Zeng H; Botnen JH; Briske-Anderson M
Nutr Cancer; 2010; 62(1):85-92. PubMed ID: 20043263
[TBL] [Abstract][Full Text] [Related]
16. Lovastatin inhibits G1/S transition of normal human B-lymphocytes independent of apoptosis.
Naderi S; Blomhoff R; Myklebust J; Smeland EB; Erikstein B; Norum KR; Blomhoff HK
Exp Cell Res; 1999 Oct; 252(1):144-53. PubMed ID: 10502407
[TBL] [Abstract][Full Text] [Related]
17. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells.
Morley KL; Ferguson PJ; Koropatnick J
Cancer Lett; 2007 Jun; 251(1):168-78. PubMed ID: 17197076
[TBL] [Abstract][Full Text] [Related]
18. The modulation of radiation-induced cell death by genistein in K562 cells: activation of thymidine kinase 1.
Jeong MH; Jin YH; Kang EY; Jo WS; Park HT; Lee JD; Yoo YJ; Jeong SJ
Cell Res; 2004 Aug; 14(4):295-302. PubMed ID: 15353126
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib toxicity is cell cycle phase specific.
Bock JM; Menon SG; Sinclair LL; Bedford NS; Goswami PC; Domann FE; Trask DK
Cancer Res; 2007 Apr; 67(8):3801-8. PubMed ID: 17440094
[TBL] [Abstract][Full Text] [Related]
20. In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines.
Tanaka R; Ariyama H; Qin B; Takii Y; Baba E; Mitsugi K; Harada M; Nakano S
Cancer Chemother Pharmacol; 2005 Jun; 55(6):595-601. PubMed ID: 15731917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]